Swift Health Systems has raised $45 million in series C funding to commercialize its INBRACE invisible orthodontics system. Financing was co-led by Vivo Capital, Novo Holdings, and venBio Partners, bringing the total capital raised by the company to more than $70 million.
The series C funding will be used to broaden the commercial availability of INBRACE through expanded orthodontist onboarding and training, increased sales and marketing resources, and consumer demand generation programs in support of existing and new INBRACE providers.
Swift Health Systems notes the growth of do-it-yourself (DIY) clear aligner therapy and how it has raised concerns among dental professionals over unsupervised treatment. INBRACE is designed to address both consumer and orthodontist needs, the company says, as a discrete, aesthetic, and convenient solution that delivers the benefits of light-force tooth movement.
“INBRACE is a real game-changer, and this latest funding will help us ensure that every INBRACE provider can finally give their patients what they’ve always wanted—a truly invisible journey to a great new smile that is convenient and shows immediate results,” said Dr. John Pham, CEO and cofounder of Swift Health Systems.
“Even with DIY orthodontic therapy on the rise, most consumers appreciate the benefits of supervised healthcare from a licensed professional. INBRACE keeps patient care in the hands of clinicians, where the overall patient experience, oral health, and treatment results are always top priorities,” said Pham.
INBRACE braces sit behind the teeth, using an all-digital platform and innovative wire and bracket designs to create the ideal smile for each patient’s unique situation, Swift Health Systems says. Patented INBRACE Smartwires are programmed using data captured from digital scans of the teeth and automate many steps in orthodontic treatment, the company adds.
The INBRACE system is designed to allow patient anatomy to naturally dictate the most efficient path for all tooth movements, resulting in increased practice efficiency and reduced overall treatment time, the company says.
“We believe that the advanced technologies behind INBRACE truly invisible braces will revolutionize the future of orthodontic treatment,” said Andrew D. Goldberg, MD, principal at Vivo Capital and future Swift board member. “The capital raised will enable Swift to advance the ways it supports patients and orthodontists around the globe.”
Related Articles
Clear Aligners Versus Brackets in Adult Orthodontics
Nighttime Aligners Require Just 10 Hours a Day
Six Strategies for Attracting Clear Aligner Patients to Your Practice